Abstract
Disulfide bond plays an important role in various fields, for example, biochemical processes, industrial and pharmaceutical chemistry, bioconjugates, peptidomimetics and selfassembled monolayers (SAMs) etc. In the past decades, drug delivery systems (DDS) have been widely investigated, and disulfide-based oxidation-reduction responsive DDS is the most promising one. Disulfide bonds have no physiological toxicity and remain stable in human body, and can be broken into a reduced form of glutathione (GSH) via the thiol-disulfide exchange reaction. Moreover, the GSH level in tumor tissues has been known to be at least 4-fold higher than that in normal tissues. Therefore, this specific redox potential in cells stimulates people to design oxidation-reduction responsive DDS for specifically releasing drugs in tumor cells and develop the new methods for the preparation of organic disulfanes. The present review has attempted to comprehensively summarize recent advances on the synthetic methods of disulfide bond in drug delivery systems.
Keywords: Disulfane synthesis, disulfide bonds, drug delivery systems, carrier, prodrug.
Current Organic Chemistry
Title:Synthetic Methods of Disulfide Bonds Applied in Drug Delivery Systems
Volume: 20 Issue: 14
Author(s): Kaiming Wang, Na Liu, Pei Zhang, Yuanyuan Guo, Yongchun Zhang, Zhongxi Zhao, Yuxia Luan, Shanzhong Li, Jianhua Cai and Jimin Cao
Affiliation:
Keywords: Disulfane synthesis, disulfide bonds, drug delivery systems, carrier, prodrug.
Abstract: Disulfide bond plays an important role in various fields, for example, biochemical processes, industrial and pharmaceutical chemistry, bioconjugates, peptidomimetics and selfassembled monolayers (SAMs) etc. In the past decades, drug delivery systems (DDS) have been widely investigated, and disulfide-based oxidation-reduction responsive DDS is the most promising one. Disulfide bonds have no physiological toxicity and remain stable in human body, and can be broken into a reduced form of glutathione (GSH) via the thiol-disulfide exchange reaction. Moreover, the GSH level in tumor tissues has been known to be at least 4-fold higher than that in normal tissues. Therefore, this specific redox potential in cells stimulates people to design oxidation-reduction responsive DDS for specifically releasing drugs in tumor cells and develop the new methods for the preparation of organic disulfanes. The present review has attempted to comprehensively summarize recent advances on the synthetic methods of disulfide bond in drug delivery systems.
Export Options
About this article
Cite this article as:
Wang Kaiming, Liu Na, Zhang Pei, Guo Yuanyuan, Zhang Yongchun, Zhao Zhongxi, Luan Yuxia, Li Shanzhong, Cai Jianhua and Cao Jimin, Synthetic Methods of Disulfide Bonds Applied in Drug Delivery Systems, Current Organic Chemistry 2016; 20 (14) . https://dx.doi.org/10.2174/1385272820666151207194002
DOI https://dx.doi.org/10.2174/1385272820666151207194002 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
Current Medicinal Chemistry Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry CD38 in Chronic Lymphocytic Leukemia: From Bench to Bedside?
Mini-Reviews in Medicinal Chemistry Editorial: [Hot Topic: TGF-β1 in Pre-Malignant and Malignant Liver Disease]
Current Pharmaceutical Design Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Anti-Cancer Agents in Medicinal Chemistry Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas
Current Angiogenesis (Discontinued) Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Current Pharmaceutical Design Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
Current Vascular Pharmacology Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Troika of the Mouse Blastocyst: Lineage Segregation and Stem Cells
Current Stem Cell Research & Therapy Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Anticancer Evaluation and Docking Study of New Bifunctional Phthalazine Derivatives
Current Organic Synthesis Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Network Pharmacology of Glioblastoma
Current Drug Discovery Technologies Safety Concerns Related to Hematopoietic Stem Cell Gene Transfer Using Retroviral Vectors
Current Gene Therapy Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation
Current Pharmaceutical Biotechnology